Integer (NYSE:ITGR) Sets New 52-Week High After Analyst Upgrade

Integer Holdings Co. (NYSE:ITGR - Get Free Report) reached a new 52-week high on Tuesday after KeyCorp raised their price target on the stock from $123.00 to $139.00. KeyCorp currently has an overweight rating on the stock. Integer traded as high as $118.36 and last traded at $118.34, with a volume of 153288 shares changing hands. The stock had previously closed at $115.40.

Several other analysts also recently issued reports on the company. Benchmark lifted their target price on Integer from $105.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, March 28th. CL King assumed coverage on shares of Integer in a research report on Thursday, March 14th. They set a "buy" rating and a $137.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $117.60.

Institutional Investors Weigh In On Integer

Large investors have recently bought and sold shares of the business. GSA Capital Partners LLP purchased a new stake in Integer during the third quarter valued at approximately $816,000. Dark Forest Capital Management LP lifted its position in Integer by 69.8% in the third quarter. Dark Forest Capital Management LP now owns 11,984 shares of the medical equipment provider's stock worth $940,000 after buying an additional 4,926 shares during the last quarter. Legacy Wealth Asset Management LLC purchased a new position in Integer during the fourth quarter worth $239,000. Nomura Holdings Inc. increased its position in Integer by 3.9% during the third quarter. Nomura Holdings Inc. now owns 180,270 shares of the medical equipment provider's stock valued at $14,139,000 after acquiring an additional 6,731 shares during the last quarter. Finally, FMR LLC raised its stake in shares of Integer by 12.8% in the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider's stock valued at $67,759,000 after acquiring an additional 97,851 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Stock Up 3.1 %

The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.71 and a current ratio of 2.80. The company's fifty day moving average price is $109.39 and its 200-day moving average price is $96.30. The stock has a market cap of $3.97 billion, a P/E ratio of 42.89, a price-to-earnings-growth ratio of 1.45 and a beta of 1.10.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.05. The business had revenue of $413.15 million during the quarter, compared to the consensus estimate of $409.04 million. Integer had a net margin of 5.68% and a return on equity of 10.80%. The firm's quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.11 earnings per share. Equities analysts forecast that Integer Holdings Co. will post 5.28 EPS for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.